Results 41 to 50 of about 16,711 (313)

Multimodal Transportation Indicators: October 2013 [PDF]

open access: yes
This statistical series was published between 2000 and 2015, under these series titles: "Transportation Indicators," "White House Economic Statistics Briefing Room: Transportation," "Key Transportation Indicators," and "Multimodal Transportation ...
United States. Department of Transportation. Bureau of Transportation Statistics
core   +1 more source

CD47 promotes mitogen‐activated protein kinase and epithelial‐to‐mesenchymal transition molecular programs to drive prometastatic phenotypes in non‐small cell lung cancer

open access: yesMolecular Oncology, EarlyView.
Beyond its role in immune evasion, this study identified that CD47 drives tumor‐intrinsic signaling in non‐small cell lung cancer (NSCLC). Transcriptomic profiling and functional studies revealed that CD47 regulates cell adhesion, migration, and metastasis through an ERK–EMT signaling axis.
Asa P.Y. Lau   +8 more
wiley   +1 more source

Multimodal Transportation Indicators: February 2015 [PDF]

open access: yes
This statistical series was published between 2000 and 2015, under these series titles: "Transportation Indicators," "White House Economic Statistics Briefing Room: Transportation," "Key Transportation Indicators," and "Multimodal Transportation ...
United States. Department of Transportation. Bureau of Transportation Statistics
core   +1 more source

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

open access: yesMolecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata   +10 more
wiley   +1 more source

Data Source Importance Evaluation for Highway Networks: A Complex Network-Based Approach

open access: yesPromet (Zagreb)
Data collection technologies or data sources are critical for highway network management. However, due to the limitations on available management resources, determining the importance of these data sources is necessary to allocate these resources ...
Huangqin HUANG   +3 more
doaj   +1 more source

A personalized recommendation system for multi-modal transportation systems

open access: yesMultimodal Transportation, 2022
Recommendation system has recently experienced widespread applications in fields like advertising and streaming platforms. Its ability of extracting valuable information from complex data makes it a promising tool for multi-modal transportation system ...
Fanyou Wu, Cheng Lyu, Yang Liu
doaj   +1 more source

Multimodal Transportation Indicators: February 2014 [PDF]

open access: yes
This statistical series was published between 2000 and 2015, under these series titles: "Transportation Indicators," "White House Economic Statistics Briefing Room: Transportation," "Key Transportation Indicators," and "Multimodal Transportation ...
United States. Department of Transportation. Bureau of Transportation Statistics
core   +1 more source

Epigenetic heterogeneity and plasticity in therapy‐induced tumor states through single‐cell multi‐omics

open access: yesMolecular Oncology, EarlyView.
Single‐cell multi‐omics reveals epigenetic heterogeneity across therapy‐adaptive tumor states, including quiescent/dormant, drug‐tolerant persister, and EMT‐like phenotypes. By linking regulatory features with state‐associated biomarkers, these approaches inform biomarker‐guided therapeutic strategies for evolving tumors.
Hee Jung Kim   +3 more
wiley   +1 more source

Multimodal Transportation Indicators: December 2014 [PDF]

open access: yes
This statistical series was published between 2000 and 2015, under these series titles: "Transportation Indicators," "White House Economic Statistics Briefing Room: Transportation," "Key Transportation Indicators," and "Multimodal Transportation ...
United States. Department of Transportation. Bureau of Transportation Statistics
core   +1 more source

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

open access: yesMolecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy